Research and Development

Projects ranging from diagnostics to diabetes care and genotyping have been given government funding as part of a new award …

Johnson & Johnson is to buy Los Angeles-based biotech firm Cougar Biotechnology for $970 million.The purchase, expected to go through …

The UK biotech sector says the government's failure to provide urgently needed financial assistance is jeopardising its future.Industry body the …

Contract research organisation Quotient Bioresearch has acquired a facility from Charles River Laboratories that will boost its capabilities in the …

Novartis says its COPD treatment has shown significant benefits over two established rivals, and could form the cornerstone of a …

Global efforts to limit the impact of the new strain of H1N1 flu virus have proven successful, but the threat …

Takeda has gained the rights to the first treatment for a new malignant bone cancer affecting children and young adults. …

Sativex, the cannabis-derived product developed by GW Pharmaceuticals, could be finally set for European approval after five years of delay. …

SkyePharma has moved ahead with plans to cut its workforce at a manufacturing plant in France by a third as …

 European pharmaceutical industry association EFPIA has unveiled a new scheme to crack down on counterfeit medicines.Beginning with a trial run …

Drug companies are not charities and are accountable to their shareholders, as we all know. Products have to be sold …

GSK has struck a deal with Oxford BioTherapeutics to develop therapies for primary, metastatic and recurring forms of cancer. The …

Sanofi-Aventis has signed an early-stage research deal with biotech Kyowa Hakko Kirin, and will receive rights to its preclinical stage …

Contract research organisation Kendle joined many of its peers in reporting a slump in demand for its clinical research services …

Boehringer Ingelheim has signed a deal with German biopharma firm DeveloGen to research and develop treatments for diabetes and obesity. …